Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea

    NEXT STORY
    Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
    PREV STORY
    Teleflex to Present at the 31st Annual Piper Jaffray Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AVACOPAN CONDITIONAL MARKETING AUTHORIZATION APPLICATION ACCEPTED FOR REGULATORY REVIEW BY EUROPEAN MEDICINES AGENCY

    Conditional marketing authorization application for treatment of patients with ANCA-associated vasculitis validated for start ...

    author_avatar
    NASDAQ Market News

    XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa

    author_avatar
    NASDAQ Market News

    RedHill Biopharma to Present at the BIO-Europe 2018 Conference

    TEL-AVIV, Israel and RALEIGH, N.C., Oct. 25, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

    author_avatar
    NASDAQ Market News